Search | IOVS | ARVO Journals

View

Showing 1 – 3 of 3

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2013

Ocular and Systemic Pharmacokinetics of a PDE4 Inhibitor Following Topical Administration (Eyedrop) in Male Dutch-Belted Rabbits

David Gale; Caroline Sychterz; Ciara Rodgers; Sherry Wang; Tom Wilde; Anu Shilpa Krishnatry; Harma Ellens

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5060. doi: https://doi.org/

Physiology and Pharmacology February 2013

Assessing a Novel Depot Delivery Strategy for Noninvasive Administration of VEGF/PDGF RTK Inhibitors for Ocular Neovascular Disease

PDF

Scott J. Robbie; Peter Lundh von Leithner; Meihua Ju; Clemens A. Lange; Andrew G. King; Peter Adamson; Dennis Lee; Caroline Sychterz; Pete Coffey; Yin-Shan Ng; James W. Bainbridge; David T. Shima
TAGS: choroidal neovascularization, melanins, pazopanib, platelet-derived growth factor, uvea, vascular endothelial growth factor a, eye
Invest. Ophthalmol. Vis. Sci.. 2013; 54(2):1490-1500. doi: https://doi.org/10.1167/iovs.12-10169

Includes: Supplemental Content

ARVO Annual Meeting Abstract March 2012

Improvement Of Corneal Staining By A Sirt1 Activator In A Mouse Model Of Dry Eye

Achim H. Krauss; Francisco Amparo; Andre Okanobo; David C. Gale; Thomas C. Wilde; Caroline Sychterz; Rachel Apfelbaum; Pratik Saha; Jennifer Cermak; Reza Dana

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2343. doi: https://doi.org/

Advertisement